seed
Stage
1
Investors
About
Hatchtech is a clinical stage company developing novel, low toxicity formulations to control ectoparasites, including the head louse Pediculus humanus capitis. The company operates out of Melbourne.
Explore Hatchtech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.